Archives
-
Cy3 Goat Anti-Human IgG: Assay Insight
2026-10-02
The Cy3 Goat Anti-Human IgG (H+L) Antibody supports sensitive human IgG visualization across fluorescence, tissue, cytometric, and ELISA workflows. This article connects reagent selection with orthopoxvirus antibody research, emphasizing species matching, endpoint interpretation, and translational assay design.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-10-01
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, immunocytochemistry, immunohistochemistry, flow cytometry, and fluorescence microscopy workflows. It is a secondary reagent for rabbit IgG detection, not a direct-detection antibody, and its sodium azide-containing formulation requires validation before use in live-cell or other azide-sensitive assays.
-
γH2AX DNA Damage Detection Kit: 5 Lab Scenarios
2026-10-01
This scenario-based guide explains how the γH2AX DNA Damage Detection Kit (Mouse mAb/Red), SKU K2275, can complement viability, proliferation, apoptosis, and genotoxicity workflows. It covers assay design, two-color imaging, protocol standardization, interpretation, and practical product-selection criteria for DNA damage and repair research.
-
XPG Mutations, Ribosome Stress, and Cockayne Syndrome
2026-09-30
This study distinguishes a Cockayne syndrome phenotype from an XP-only phenotype caused by mutations in the same XPG gene. Its central contribution is linking the Cockayne syndrome cellular state to defective RNA polymerase I activity, impaired rRNA maturation, eIF2α phosphorylation, and a shift toward IRES-dependent translation, thereby implicating ribosomal stress and translational control in disease pathogenesis.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody
2026-09-30
HRP Goat Anti-Rabbit IgG (H+L) Antibody provides an HRP-labeled secondary reagent for detecting rabbit IgG primary antibodies in Western blot, ELISA, IHC, and ICC workflows. It should be used with rabbit primaries and assay-appropriate controls, not as a universal secondary antibody, diagnostic reagent, or substitute for primary-antibody validation.
-
ELISA Stop Solution in Quantitative Immunoassays
2026-09-29
Learn how ELISA Stop Solution controls endpoint chemistry, improves plate-to-plate consistency, and supports interpretation of vaccine immunogenicity data. This guide connects assay design with findings from a bivalent H5/H7 mRNA–LNP vaccine study.
-
3X (DYKDDDDK) Peptide: Workflow Guide
2026-09-29
Use the 3X FLAG peptide to improve competitive elution, confirm FLAG fusion proteins, and control metal-sensitive immunoassays. This practical guide connects recombinant protein workflows with structural insights from human PSS2 research, while emphasizing assay controls and troubleshooting.
-
ASB3 Targets MAVS to Suppress Antiviral Immunity
2026-09-28
The 2024 Cell Death & Differentiation study identifies ASB3 as an E3 ubiquitin ligase that suppresses antiviral innate immunity by promoting K48-linked ubiquitination and proteasomal degradation of MAVS at K297. Its genetic, biochemical, infection, and animal-model evidence positions ASB3 as a negative regulator of RIG-I-like receptor signaling and provides a framework for experimentally validating MAVS-centered antiviral mechanisms.
-
NETosis and IL-36R Feedback in Psoriasis
2026-09-28
The study links TLR3- and P2X7R-associated signals to neutrophil extracellular trap formation and identifies IL-36R signaling as an amplifier of inflammatory responses in psoriasis models. Its findings support further investigation of the NET–IL-36R relationship while highlighting the importance of disease timing and model-specific validation.
-
Homoharringtonine Against SARS-CoV-2: Evidence and Limits
2026-09-27
A 2025 study reports that homoharringtonine suppressed replication of four tested coronaviruses and was associated with rapid upper-respiratory SARS-CoV-2 clearance in mouse and small human cohorts. The findings support further investigation of this protein-elongation inhibitor as a locally delivered antiviral candidate, but do not establish clinical efficacy, safety, or first-line use.
-
FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflows
2026-09-26
Translate a mechanistic study of lycopene and T-2 toxin into practical fluorescence assays for testicular and Leydig-cell research. This guide shows how to use a FITC secondary for rabbit-primary detection, with starting conditions, controls, and troubleshooting that keep biological interpretation separate from reagent performance.
-
Western Secondary Antibody Dilution Buffer for Blots
2026-09-25
Improve Western blot consistency when testing macrophage inflammatory pathways with a secondary antibody diluent formulated to limit background and support antibody reuse. This workflow connects the octanal–Olfr2–NHE1 atherosclerosis findings to practical protein-detection choices without confusing assay optimization with biological evidence.
-
Dietary Arachidonic Acid Boosts Vaccine Humoral Immunity
2026-09-25
The study reports that dietary arachidonic acid (ARA) enhances rabies-vaccine neutralizing antibody responses in mice and accelerates antibody development in human volunteers. Its mechanistic findings implicate lymph-node ARA metabolism and a prostaglandin I2–cAMP–PKA pathway affecting B-cell activation, while leaving dose, safety, and generalizability questions for further study.
-
Batimastat (BB-94) and Local BDNF Processing
2026-09-24
Explore how Batimastat (BB-94) can help test the role of extracellular MMP activity in spatially organized BDNF processing at developing neuromuscular junctions. This article separates evidence from hypothesis and translates a recent study into practical assay-design decisions.
-
3X FLAG Peptide for Membrane-Protein Research
2026-09-24
The 3X (DYKDDDDK) Peptide can support detection and recovery of tagged proteins, but membrane-contact biology demands careful assay design. Using MIGA2 lipid-transfer research as a case study, this article explains how to separate tag performance from protein function and lipid-dependent assay effects.